Dr. Chok received his PhD in Business Administration from the University of Southern California (USC) and joined academia after several years of professional experience working in a variety of organizations outside the United States. A significant part of his employment experience was developed in varied institutional contexts across transnational organizations such as the World Bank Group and ExxonMobil, and across large government agencies such as the military and the Treasury (the Singapore Ministries of Finance and Defense). Dr. Chok has also held research positions at three very different educational institutions (INSEAD, the Nanyang Technological University in Singapore, and USC Marshall) before teaching at KGI. Since coming to KGI, Dr. Chok has served as faculty advisor for Team Master’s Project (TMP) sponsored by industry clients including Tecan, Eli Lilly and Company, Yumei Hospital, and Aochi Biotech.
Chok JI. “Regulatory dependence and Scientific Advisory Boards”. Research Policy 2009;38(5):710-25 (Recipient of the USC Phi Kappa Phi Student Recognition Award)
Chok JI, Sun Q. “Determinants of idiosyncratic volatility for biotech IPO firms”. Financial Management 2007;36(4):107-22
Kennedy MT, Chok JI, Liu J. “What does it mean to be green? Theory and method for observing changing criteria of corporate reputation”. In The Oxford Handbook of Corporate Reputation. Oxford University Press; 2012
Chok JI. “Raising Capital with Uncertainty: Overpricing Initial Public Offering for Science-Based Firms with Multiple Ties to the Food and Drug Administration”. In: Cozzens SE, Catalan P, editors. Georgia Institute of Technology; 2009
Ling J, Chok JI. “The effects of organizational bureaucracy and capital constraints on the development of entrepreneurial cognition”, Journal of Applied Management and Entrepreneurship, 2013, Vol 18, No.2